Investing

How Do Medicaid Cuts Threaten Everyone's Care?
Business How Do Medicaid Cuts Threaten Everyone's Care?

At the helm of L.A. Care, the nation’s largest public health plan, Martha Santana-Chin oversees the well-being of over 2.2 million people. But for her, this work is not just professional; it is deeply personal. As a child of Mexican immigrants, she and her family relied on Medi-Cal, C

Security and Compliance Now Drive Healthcare IoT
Technology Security and Compliance Now Drive Healthcare IoT

The strategic decisions being made today within the highly regulated landscape of connected healthcare are creating the governance playbook that will guide mission-critical IoT deployments across all industries tomorrow. Long past the phase of speculative pilot programs, the Healthcare Internet of

Can AI Bridge the Gap Between Care and Billing?
Process Can AI Bridge the Gap Between Care and Billing?

The chasm separating the delivery of patient care from the administrative complexities of billing has become a primary source of financial instability for healthcare organizations nationwide. While clinicians dedicate themselves to healing, their efforts are frequently devalued by a documentation

Healthcare and Life Sciences Expect an M&A Surge
Business Healthcare and Life Sciences Expect an M&A Surge

Today we're joined by Faisal Zain, a veteran expert in medical technology whose career has been dedicated to advancing the manufacturing and innovation of critical diagnostic and treatment devices. His deep understanding of the intersection between technology and healthcare finance provides a

Can New Funding Fix Clinical Trial Patient Recruitment?
Organizational Governance Can New Funding Fix Clinical Trial Patient Recruitment?

The journey of a life-saving drug from a laboratory concept to a patient’s hands is one of the most complex and expensive undertakings in modern science, yet it is often stalled not by scientific complexity, but by the profoundly human challenge of finding the right people to participate in c

Is Innovation Enough for Biopharma's Survival?
Care Is Innovation Enough for Biopharma's Survival?

The echo of groundbreaking scientific achievement in the biopharmaceutical sector is being increasingly muffled by the persistent drumbeat of an unsustainable business model, creating a dissonance that threatens the industry's long-term health. An exhaustive analysis of strategic forecasts and

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later